Brittany Gerst

United States Supreme Court (1 summary)

Merck Sharp & Dohme Corp. v. Albrecht

Absence of “clear evidence that the FDA would not approve a change to a label, the Court will not conclude that it was impossible… to comply with both federal and state requirements.”

Area(s) of Law:
  • Preemption

Back to Top